Finbar Larkin
SVP, Technical Development, Jazz Pharmaceuticals.
Companies
- Jazz PharmaceuticalsSVP, Technical Development Nov 7, 2019 to Mar 7, 20231
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Jazz Pharmaceuticals JAZZ21,779 shares2$4.7M at $214.42Mar 7, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 7, 2023Sold 2,075 shares at $140.76 of Jazz Pharmaceuticals2
- Mar 6, 2023Sold 1,706 shares at $143.92 of Jazz Pharmaceuticals2
- Mar 6, 2023Exercised options 1,706 shares at $58.72 of Jazz Pharmaceuticals2
- Mar 3, 2023Granted 4,373 shares of Jazz Pharmaceuticals2
- Nov 14, 2022Sold 197 shares at $149.33 of Jazz Pharmaceuticals3
- Sep 7, 2022Sold 63 shares at $150.00 of Jazz Pharmaceuticals4
- May 9, 2022Sold 1,747 shares at $148.94 of Jazz Pharmaceuticals5
- Mar 3, 2022Granted 4,621 shares of Jazz Pharmaceuticals6
- Nov 12, 2021Sold 197 shares at $135.79 of Jazz Pharmaceuticals7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Nov 16, 2022
- 4SEC EDGARForm 4 filed Sep 9, 2022
- 5SEC EDGARForm 4 filed May 11, 2022
- 6SEC EDGARForm 4 filed Mar 9, 2022
- 7SEC EDGARForm 4 filed Nov 16, 2021